Activities

Harm Reduction and the Opioid Syndemic

This module focuses on best practices in harm reduction as Kentucky is among the states leading the country in HCV infections. It is critical for professionals to have current knowledge to provide effective treatment and education for patients.

This activity has been approved by the KBML as meeting the statutory requirements of HB1.

Faculty

Activity Details

  • CreditAmounts:
    • CME: 0.50
    • CPE: 0.50
    • Other: 0.50
    • CDE: 0.50
  • Type: Video Webcast Video Activity
  • Expires: Apr 13, 2022
  • Cost: Free
Learn More
Heroin And Fentanyl: Lab Perspective

Drug overdose is a huge problem facing the health care system in Kentucky. Drug overdose deaths are acute poisoning deaths due to prescription or illicit drugs. According to data from the National Center for Health Statistics, Kentucky had the 2nd highest drug overdose death rate in the US in 2013.

KENTUCKY INJURY PREVENTION AND RESEARCH CENTER Faculty

Activity Details

  • CreditAmounts:
    • CME: 0.50
    • Other: 0.50
    • CDE: 0.50
    • CPHCE: 1.00
  • Type: Video Webcast Video Activity
  • Expires: Sep 3, 2022
  • Cost: Free
Learn More
The Opioid Crisis

Addiction to prescription opioids and heroin has become a national emergency. This module provides clinicians with a description of the epidemic and its effective treatments.

This activity has been approved by the KBML as meeting the statutory requirements of HB1.

Faculty

Activity Details

  • CreditAmounts:
    • CME: 0.75
    • Other: 0.75
    • CPHCE: 1.00
  • Type: Video Webcast Video Activity
  • Expires: Sep 9, 2022
  • Cost: Free
Learn More
HCV Screening and Linkage to Care: The Norton Experience

Current CDC guidelines recommend universal screening of patients born between 1945 and 1965 as well as other patients based on risk.

All eligible patients are not being screened and patients with risky exposures/behaviors are difficult to link to care.

This activity has been approved by the KBML as meeting the statutory requirements of HB1.

Faculty

Activity Details

  • CreditAmounts:
    • CME: 0.50
    • Other: 0.50
    • CDE: 0.50
  • Type: Video Webcast Video Activity
  • Expires: Sep 3, 2022
  • Cost: Free
Learn More
Screening/Testing for HCV

The USPSTF recommends screening for hepatitis C virus (HCV) infection in persons at high risk for infection. The USPSTF also recommends offering 1-time screening for HCV infection to adults born between 1945 and 1965.

Faculty

Activity Details

  • CreditAmounts:
    • CME: 0.75
    • Other: 0.75
    • CPHCE: 1.00
  • Type: Video Webcast Video Activity
  • Expires: Sep 7, 2022
  • Cost: Free
Learn More
Hep C: Issues in PWID

Hepatitis C treatment is often withheld from PWID due to concerns regarding adherence, perceived lack of efficacy, and perceived risk of reinfection. PWID are a difficult to reach population leading to lower rates of linkage to care. Failure to address HCV in PWID will lead to failure to eradicate HCV.

This activity has been approved by the KBML as meeting...

Faculty

Activity Details

  • CreditAmounts:
    • CME: 0.00
    • Other: 0.50
    • CPHCE: 1.00
  • Type: Video Webcast Video Activity
  • Expires: Sep 4, 2022
  • Cost: Free
Learn More
Post-HCV Treatment Follow-up and Reinfection

Virologic cure of hepatitis C does not mean a cure of advanced liver disease. Ongoing evaluation and management of liver disease is indicated for cirrhotic patients after achieving SVR. Non-hepatologist HCV care providers are not familiar with management of cirrhosis.

This module will increase knowledge of appropriate screening to prevent liver complications post SVR.Faculty

Activity Details

  • CreditAmounts:
    • CME: 0.75
    • Other: 0.75
    • CPHCE: 1.00
  • Type: Video Webcast Video Activity
  • Expires: Sep 5, 2022
  • Cost: Free
Learn More